Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Roblox launches IP licensing platform

Digest more
 · 19h · on MSN
Roblox Launches New Licensing Platform With Lionsgate, Netflix, Sega and Kodansha as Founding Partners (EXCLUSIVE)
Roblox is launching a new licensing platform to streamline the process for IP rights holders to partner with creators on the gaming platform. Beginning Tuesday, Roblox is teaming with Netflix, Lionsgate,

Continue reading

 · 18h · on MSN
Roblox launches IP licensing platform, partners with Netflix, Lionsgate
 · 12h · on MSN
Netflix & Lionsgate Join Initiative To Bring More Blockbuster Film & TV Properties To Roblox
Marketing-Interactive
2h
Roblox opens the IP floodgates for creators and brands
Roblox is rewriting the rules of branded experiences with the launch of a new self-serve licensing platform, making it easier ...
15hon MSN
Roblox creators can now make their own Stranger Things and Twilight games
Roblox is launching a new licensing platform that will make it easier for companies to offer their intellectual property (IP) ...
16h
What's Going On With Roblox Stock On Tuesday?
Roblox shares edge higher as it launches a licensing platform to simplify IP access for creators and attract major media ...
29d
Train a virtual dragon? Film studios turn to Roblox and other games to reach young fans
From creating virtual experiences to selling tickets within games and social media, Hollywood is trying to capture the attention of young fans in places they frequent.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy